Evidence map›Paper›PMID 36941004›Full record

ArticleBMJ global health2023

A comprehensive and healthcare equity promoting response by a civil society-public partnership to COVID-19 in Chiapas, Mexico.

Ana Laura Rodríguez, Zeus Aranda, Elvire Brun, Samuel DiChiara, Alondra Esquinca, Erick González, Sebastián González, Ariwame Jiménez, César Uberto Molina-Orozco, Laura Martínez and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Community participation in responding to health misinformation.International journal for equity in health · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Ana Laura RodríguezCompañeros En Salud, Ángel Albino Corzo, Mexico.
Zeus ArandaCompañeros En Salud, Ángel Albino Corzo, Mexico zeusaranda213@gmail.com.ORCID 0000-0001-5272-1967
Elvire BrunCompañeros En Salud, Ángel Albino Corzo, Mexico.
Samuel DiChiaraCompañeros En Salud, Ángel Albino Corzo, Mexico.
Alondra EsquincaCompañeros En Salud, Ángel Albino Corzo, Mexico.
Erick GonzálezSecretaria de Salud del Estado de Chiapas, Ángel Albino Corzo, Mexico.
Sebastián GonzálezCompañeros En Salud, Ángel Albino Corzo, Mexico.
Ariwame JiménezCompañeros En Salud, Ángel Albino Corzo, Mexico.
César Uberto Molina-OrozcoSecretaria de Salud del Estado de Chiapas, Ángel Albino Corzo, Mexico.
Laura MartínezCompañeros En Salud, Ángel Albino Corzo, Mexico.
Jaren MullenCompañeros En Salud, Ángel Albino Corzo, Mexico.
Bruno VargasCompañeros En Salud, Ángel Albino Corzo, Mexico.
Sandra VázquezCompañeros En Salud, Ángel Albino Corzo, Mexico.
Selene Chacón-HernándezCompañeros En Salud, Ángel Albino Corzo, Mexico.
Instituto Nacional de Salud Pública · MXSecretaria de Salud · MXEl Colegio de la Frontera Sur · MXEsSALUD · PETulane University · USUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the first COVID-19 case in Chiapas, Mexico in March 2020, the non-governmental organisation Compañeros En Salud (CES) and the state's Ministry of Health (MOH) decided to join forces to respond to the global pandemic. The collaboration was built over 8 years of partnership to bring healthcare to underserved populations in the Sierra Madre region. The response consisted of a comprehensive SARS-CoV-2 infection prevention and control programme, which included prevention through communication campaigns to combat misinformation and stigma related to COVID-19, contact tracing of suspected and confirmed COVID-19 cases and their contacts, outpatient and inpatient care for patients with respiratory symptoms, and CES-MOH collaboration on anti-COVID-19 immunisation campaigns. In this article, we describe these interventions and their principal outcomes, as well as reflect on notable pitfalls identified during the collaboration, and we suggest a series of recommendations to prevent and mitigate their occurrence. As with many cities and towns across the globe, the poor preparedness of the local health system for a pandemic and pandemic response led to the collapse of the medical supply chain, the saturation of public medical facilities and the exhaustion of healthcare personnel, which had to be overcome through adaptation, collaboration and innovation. For our programme in particular, the lack of a formal definition of roles and clear lines of communication between CES and the MOH; thoughtful planning, monitoring and evaluation and active engagement of the communities served in the design and implementation of health interventions affected the outcomes of our efforts.

Indexed as

COVID-19Communicable Disease ControlGovernment AgenciesHumansMexicoOrganizationsPandemicsCOVID-19descriptive studyhealth systemsprevention strategiespublic health

Identifiers

PMID36941004
PMCPMC10030274
OpenAlexW4327937850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.